Howard Marks’s Alvotech ALVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$362K Sell
97,982
-142,056
-59% -$508K 0.01% 143
2026
Q1
$339K Sell
240,038
-293,618
-55% -$1.29M 0.01% 145
2025
Q4
$2.02M Sell
533,656
-1,030,020
-66% -$6.51M 0.03% 146
2025
Q3
$12.8M Hold
1,563,676
0.2% 84
2025
Q2
$14.3M Sell
1,563,676
-304,807
-16% -$2.86M 0.25% 61
2025
Q1
$18.1M Sell
1,868,483
-57,222
-3% -$694K 0.35% 49
2024
Q4
$25.5M Sell
1,925,705
-606,322
-24% -$7.47M 0.45% 44
2024
Q3
$30.1M Hold
2,532,027
0.48% 39
2024
Q2
$30.8M Sell
2,532,027
-367,174
-13% -$4.91M 0.49% 29
2024
Q1
$35.4M Sell
2,899,201
-2,551,695
-47% -$37.3M 0.56% 28
2023
Q4
$62.6M Buy
5,450,896
+407,391
+8% +$3.84M 0.91% 27
2023
Q3
$46M Sell
5,043,505
-1,715,655
-25% -$15.9M 0.67% 27
2023
Q2
$52.3M Sell
6,759,160
-1,003,473
-13% -$9.34M 0.69% 29
2023
Q1
$100M Buy
7,762,633
+1,423,973
+22% +$18.2M 1.11% 19
2022
Q4
$63.4M Hold
6,338,660
0.67% 27
2022
Q3
$42.8M Hold
6,338,660
0.47% 32
2022
Q2
$52M Buy
+6,338,660
New +$59M 0.6% 29

Other funds holding ALVO

Howard Marks's ALVO Position: Q2 2026 in Review

Howard Marks reduced its Alvotech (ALVO) stake by 59% in Q2 2026, selling an estimated $508K and leaving 97,982 shares worth $362K. The position accounts for 0.01% of the portfolio, ranked #143.

Howard Marks first reported a position in ALVO in Q2 2022 and has held it in 17 quarters since. The position peaked at $100M in Q1 2023. 72 funds tracked by Wall St. Rank hold ALVO as of Q2 2026.

  • Howard Marks held 97,982 shares of Alvotech worth $362K as of Q2 2026.
  • Howard Marks sold 142,056 Alvotech shares in Q2 2026, an estimated $508K.
  • Alvotech made up 0.01% of Howard Marks's portfolio in Q2 2026, its #143 holding.
  • Howard Marks first reported a position in Alvotech in Q2 2022 and has held it in 17 quarters since.
  • Howard Marks's Alvotech position peaked at $100M in Q1 2023.
  • 72 funds tracked by Wall St. Rank held Alvotech as of Q2 2026.

Based on Oaktree Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.